Co-Founder, Chairman, CEO

Chief Commercial Officer (CCO)

Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review

Certain Common Stock of Celcuity Inc. are subject to a Lock-Up Agreement Ending on 29-SEP-2025.

Certain Pre-Funded Warrants of Celcuity Inc. are subject to a Lock-Up Agreement Ending on 29-SEP-2025.

Associate Director/Director, Clinical Scientist

Celcuity is a clinical-stage biotechnology company focused on developing targeted therapies for cancer treatment. They are seeking an Associate Director/Director, Clinical Scientist to contribute strategically to Clinical Development goals and collaborate with Medical Directors and Clinical Development activities.

Sign up with Google

Sign in with Google